|
 |
REMICADE
Remicade (also known as Infliximab), is manufactured by the Johnson & Johnson subsidiary, Centocor. Remicade is used to treat Crohn's Disease and Rheumatoid Arthritis. Remicade was first approved by the FDA on August 24, 1998. Remicade was specifically approved for Rheumatoid Arthritis on November 10, 1999. Remicade is made from a combination of mouse and human substances and is administered intravenously, at a doctor's office or hospital. The patient is given 3 mg/kg as a single dose. The initial dose should be followed by additional 3 mg/kg doses two and six weeks after the first dose. The maintenance dose is 3 mg/kg every eight weeks. Patients often take Methotrexate simultaneously with Remicade treatments. Tumor necrosis factor (TNF) plays a key role in the response of the body's immune system to infections. The action of blocking TNF may worsen or increase the occurrence of infections. Remicade blocks the effects of TNF-alpha. A "black box warning" is the strongest consumer warning available to drug manufacturers. On August 15, 2001, Centocor announced that a "black box warning" had been added to Remicade's label in order to better inform doctors and patients of the increased chance of developing tuberculosis while receiving Remicade treatments. This increased warning followed allegations that Remicade has been associated with 84 cases of tuberculosis and at least 14 deaths. If you or a loved one has suffered an injury as a result of Remicade, call J.P. Gonzalez-Sirgo, P.A. at (305) 461-1095 or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations so please call right away to ensure that you do not waive your right to possible compensation. The hiring of a lawyer is an important decision that should not be based solely upon advertisments. Before you decide, ask us to send you free written information about our qualifications and experience. The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own legal situation. Copyright © 2005 J. P. Gonzales-Sirgo
– Florida personal injury attorneys, motor vehicle accident lawyers and medical malpractice
attorneys, serving Miami, Coral Gables and cities throughout Southern Florida.
Lawyer
Websites – Attorney Websites – Law Firm Websites designed by MegaHunter, Inc.
Florida Remicade Injury Lawyers Disclaimer: The Florida Remicade injury, pharmaceutical litigation, drug injury, personal injury and/or other legal information offered herein by J. P. Gonzales-Sirgo, Florida Remicade Injury Lawyers, is not formal legal advice nor the formation of an attorney client relationship. Any results set forth herein are based only upon the facts of that particular case and offer no promise or guarantee on the outcome of any case. This site is not intended to solicit clients outside the State of Florida. |
 |